This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
The Zacks Analyst Blog Highlights: UNH, CNC, HUM, ANTM and HCA
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UNH, CNC, HUM, ANTM and HCA
Centene (CNC) Offers Senior Unsecured Notes Valued $2.2B
by Zacks Equity Research
Centene (CNC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.
Uncertainty Over Supreme Court Ruling Weighs on Healthcare
by Zacks Equity Research
Health insurers and hospital stocks depreciate after Justice Ruth Bader Ginsburg who defended the Obamacare breathes her last.
Humana (HUM) Ties Up to Boost Medicare Network in New Jersey
by Zacks Equity Research
Humana (HUM) forges partnership with AtlantiCare to enhance its presence in New Jersey as well as provide better healthcare to its members.
Centene Ties Up to Expand Telehealth Services in Rural Areas
by Zacks Equity Research
Centene (CNC) partners with Samsung Electronics America to make telehealth offerings available in rural and underserved areas.
Humana's New Value-Based Care Plans to Better Healthcare
by Zacks Equity Research
Humana's (HUM) enriched value-based care programs are expected to curtail expenses as well as boost quality of healthcare.
Humana (HUM) Taps Salesforce for Better Healthcare Services
by Zacks Equity Research
Humana (HUM) teams up with Salesforce to provide improved healthcare services for its members.
Sportsman's Warehouse, DXP Enterprises, Anthem and Centene Corp highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Sportsman's Warehouse, DXP Enterprises, Anthem and Centene Corp highlighted as Zacks Bull and Bear of the Day
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which is a more profitable bet based on fundamentals.
UnitedHealth to Aid Eligible Medicaid Members in Indiana
by Zacks Equity Research
UnitedHealth Group (UNH) intends to improve health outcomes of Medicaid members in Indiana, where it already has a strong presence.
Why Is Centene (CNC) Down 10.5% Since Last Earnings Report?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Centene's Contract Renewal to Aid Medicaid Members in Indiana
by Zacks Equity Research
Centene's (CNC) subsidiary MHS gets a contract renewal through which it will be able to efficiently serve its Medicaid members in Indiana.
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Banking on an upbeat outlook and rising membership, Anthem (ANTM) holds immense potential to reap benefits for investors.
Here's Why You Should Add Humana (HUM) to Your Portfolio
by Zacks Equity Research
Riding high on its Medicare line of business and strategic initiatives, Humana (HUM) holds enough potential to reap benefits for investors.
Molina Healthcare (MOH) Surges 44.1% YTD: More Room to Run?
by Zacks Equity Research
Molina Healthcare's (MOH) rising membership is likely to boost its revenues, which in turn, might perk up in share price.
Cigna (CI) Earnings Surpass Estimates in Q2, Improve Y/Y
by Zacks Equity Research
Cigna's (CI) Q2 earnings gain from a strong fundamental performance and reduced medical costs from delayed treatments amid the COVID-19 pandemic.
Company News for Jul 29, 2020
by Zacks Equity Research
Companies in the news are: CNC, CMI, LW, IVZ
Centene's (CNC) Q2 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Centene's (CNC) second-quarter results reflect robust revenues.
Centene (CNC) Misses Q2 Earnings Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of -0.42% and 1.21%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Centene (CNC)
by Zacks Equity Research
Centene (CNC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in the Cards for Centene's (CNC) Q2 Earnings?
by Zacks Equity Research
Centene's (CNC) Q2 results are likely to reflect better revenues, partly offset by the COVID-19 impact.
Universal Health (UHS) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Universal Health's (UHS) second-quarter results are likely to reflect muted revenues.
HCA Healthcare's (HCA) Q2 Earnings Beat Estimates, Fall Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results reflect lower expenses, partly offset by a decline in admissions.
Centene (CNC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molina Healthcare's Buyout Deal to Boost Its Base in Kentucky
by Zacks Equity Research
Molina Healthcare's (MOH) upcoming acquisition will fortify its presence in the Kentucky market.